OTC Markets Hosts Virtual Investor Presentation with Christian Kanstrup, CEO of Evaxion Biotech, and Brad Sorensen, Senior Analyst at Zacks SCR [Yahoo! Finance]
Evaxion Biotech A/S - American Depositary Share (EVAX)
Company Research
Source: Yahoo! Finance
My name is Anthony Kraus and on behalf of OTC Markets, as well as our co-host, Zacks Small Cap Research, we're very pleased you have joined us for our next live presentation from the Evaxion Biotech. Our session will be moderated by Brad Sorensen, Senior Equity Research Analyst with Zacks Small Cap Research. Please note you can submit questions for the presenter in the box to the left of the slides. You can also view a company's availability for one-on-one meetings through the Schedule Meetings tab found on the conference platform. At this point, I'm very pleased to welcome Christian Kanstrup, Chief Executive Officer of Evaxion Biotech which trades on Nasdaq under the symbol EVAX. Welcome, Christian. Christian Kanstrup: Thank you so much. Brad Sorensen: Great to be here. Thanks for joining us. Full disclosure, I cover Evaxion, and I'm really excited about the story they tell. Hopefully, you guys have read some of the research that I put out because it's a really exciting story. On
Show less
Read more
Impact Snapshot
Event Time:
EVAX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
EVAX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
EVAX alerts
High impacting Evaxion Biotech A/S - American Depositary Share news events
Weekly update
A roundup of the hottest topics
EVAX
News
- Strong validation of Evaxion’s AI-Immunology™ platform in multiple clinical trialsGlobeNewswire
- Recent clinical data confirms significantly improved predictive power of Evaxion's AI-Immunology™ platformGlobeNewswire
- Evaxion Biotech A/S (NASDAQ: EVAX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $14.00 price target on the stock.MarketBeat
- Evaxion significantly expands vaccine development collaboration with MSDGlobeNewswire
- Evaxion Biotech A/S (NASDAQ: EVAX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $14.00 price target on the stock.MarketBeat
EVAX
Sec Filings
- 10/9/24 - Form 6-K
- 10/4/24 - Form 6-K
- 10/3/24 - Form 6-K
- EVAX's page on the SEC website